Under insulin-resistant conditions where the pathway-specific impairment in PI3K-dependent signaling occurs, the imbalance between NO and ET-1 may result in endothelial dysfunction with subsequent cardiovascular events. The gene discussed is INS; the disease is endothelial dysfunction.